Development of CP506 a novel hypoxia-selective cytotoxin for the treatment of triple negative breast cancer (TNBC)
Login
University Home
→
Library
JavaScript is disabled for your browser. Some features of this site may not work without it.
Development of CP506 a novel hypoxia-selective cytotoxin for the treatment of triple negative breast cancer (TNBC)
Moore, Sarah
Identifier:
http://hdl.handle.net/2292/48966
Issue Date:
2019
Degree Grantor:
The University of Auckland
Rights:
Copyright: The author
Rights (URI):
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
Description:
Thesis embargoed until 11/2021.
Show full item record
Files in this item
This item appears in the following Collection(s)
Masters Theses - Embargo
[42]
Share
Search ResearchSpace
Search ResearchSpace
This Collection
Browse
All of ResearchSpace
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Statistics
View Usage Statistics
